Despite most of the available evidence pointing to the contrary, it remains a popular misconception that AIDS in Africa is a distinct disease from that suffered in industrialized nations.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Triple NF-kB binding sites and LTR sequence similarities in HIV-1C isolates irrespective of helminth co-infection
Parasites & Vectors Open Access 29 April 2014
-
Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection
Retrovirology Open Access 07 March 2008
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Colebunders, R. et al. Seroconversion rate, mortality and clinical manifestations associated with the receipt of a human immunodeficiency virus-infected blood transfusion in Kinshasa, Zaire. J. Infect. Dis. 164, 450–456 (1991).
N'Galy, B. et al. Human immunodeficiency virus infection among employees in an African hospital. N. Engl. J. Med. 319, 1123–1127 (1988).
Whittle, H. et al. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection. AIDS 6, 685–689 (1992).
Mann, J.M. et al. Natural history of human immunodeficiency virus infection in Zaire. Lancet 2, 707–709 (1986).
Marlink, R. et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265, 1587–1590 (1994).
Leroy, V. et al. Four years of natural history of HIV-1 infection in African women: a prospective cohort study in Kigali (Rwanda), 1988–1993. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 9, 415–421 (1995).
French, N. et al. Immunological and clinical stages in HIV-1 infected adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 22, 509–516 (1999).
Morgan, D. et al. Natural history of HIV infection in rural Uganda—results after 10 years. Abstract TuOr428. XIII International AIDS Conference, Durban 9–14 July 2000.
UNAIDS. Report on the global HIV/AIDS epidemic, June 2000. Geneva 2000
Hendriks, J.C.M. et al. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data accounting for death prior to an AIDS diagnosis. AIDS 12, 1537–1544 (1998).
Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active retroviral therapy: a collaborative re-analysis. Lancet 355, 1131–1137 (2000).
Koblin, B.A. et al. Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978–1995. Am. J. Epidemiol. 150, 1026–1030 (1999).
van Benthem, B.H.B. et al. Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental seroconvertor study. AIDS 12, 1039–1045 (1998).
Touloumi, G. et al. Determinants of progression of HIV infection in a Greek Haemophilia cohort followed for up to 16 years after seroconversion. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 19, 89–97 (1998).
World Health Organization. Acquired immunodeficiency syndrome. WHO/CDC case definition for AIDS. Wkly. Epidemiol. Rec. 61, 69–72 (1986).
World Health Organization. Acquired immunodeficiency syndrome (AIDS). Interim proposal for a WHO staging system for HIV infection and disease. Wkly. Epidemiol. Rec. 65, 221–228 (1990).
Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb. Mortal. Wkly. Rep. 41 (RR-17), 1–19 (1992).
Anzala, O.A. et al. Rapid progresion to disease in African sex workers with human immunodeficiency virus type 1 infection. J. Infect. Dis. 171, 686–689 (1995).
Bwayo, J.J. et al. Comparison of the declines in CD4 counts in HIV-1-seropositive female sex workers and women from the general population in Nairobi, Kenya. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 10, 457–461 (1995)
Anzala, A.O. et al. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. J. Infect. Dis. 182, 59–66 (2000).
Morgan, D. et al. Survival by AIDS defining condition in rural Uganda. Sex. Transm. Infect. 76, 193–197 (2000).
Friedland, G.H. et al. Survival differences in patients with AIDS. J. Acquir. Immune Defic. Syndr. 4, 144–153 (1991).
Lemp, G.F. et al. Survival trends for patients with AIDS. JAMA 263, 402–406 (1990).
Moore, R.D. et al. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N. Engl. J. Med. 324, 1412–1416 (1991).
Rogers, P.A. et al. Survival of adults with AIDS in the United Kingdom. Commun. Dis. Rep. Rev. 7, R93–R100 (1997).
Ghirardini, A. et al. Survival after AIDS among Italian haemophiliacs with HIV infection. The Italian Group on Congenital Coagulopathies. AIDS 9, 1351–1356 (1995).
Mouton, Y. et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS 11, F101–105 (1997).
Moore, R.D. & Chaisson R.E. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 13, 1933–1942 (1999).
Whalen, C. et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N. Engl. J. Med. 337, 801–808 (1997).
Anglaret, X. et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1 infected adults in Abidjan, Côte d'Ivoire: a randomised trial. The Co-trimo-CI study group. Lancet 353, 1463–1468 (1999).
Wiktor, S.Z. et al. Efficacy of trimethoprim-sulphamethoxazole chemoprophylaxis to decrease morbidity and mortality in HIV-1 associated tuberculosis in Côte d'Ivoire: a randomised controlled trial. Lancet 353, 1469–1475 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morgan, D., Whitworth, J. The natural history of HIV-1 infection in Africa. Nat Med 7, 143–145 (2001). https://doi.org/10.1038/84564
Issue Date:
DOI: https://doi.org/10.1038/84564
This article is cited by
-
Triple NF-kB binding sites and LTR sequence similarities in HIV-1C isolates irrespective of helminth co-infection
Parasites & Vectors (2014)
-
Natural history of HIV infection in former plasma donors in rural China
Frontiers of Medicine in China (2010)
-
Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection
Retrovirology (2008)
-
Gulliver's travels in HIVland
Nature (2001)